Combining the nicotine inhaler and nicotine patch for smoking cessation

Published

Journal Article

Objective: To assess the combination of the nicotine inhaler and nicotine patch for smoking cessation. Methods: Thirty healthy volunteers were enrolled into this open-label clinical trial of the combined use of nicotine inhalers and patches (15mg/16hr) for 6 weeks, and then nicotine inhalers alone for an additional 6 weeks. Results: Compared to baseline, the percentage salivary cotinine replacement at the end of Week 1 was 74%. One week point abstinence at 6 weeks was 43.3% (95% CL=26%, 61%), and at 12 weeks was 30.0% (95% CL=14%, 46%). Conclusion: The combination of the nicotine inhaler and nicotine patch appears safe and tolerable when used for smoking cessation.

Full Text

Duke Authors

Cited Authors

  • Westman, EC; Tomlin, KF; Rose, JE

Published Date

  • January 1, 2000

Published In

Volume / Issue

  • 24 / 2

Start / End Page

  • 114 - 119

International Standard Serial Number (ISSN)

  • 1087-3244

Digital Object Identifier (DOI)

  • 10.5993/AJHB.24.2.4

Citation Source

  • Scopus